{"id":"pgl4001-progestin-drug-free-period","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Irregular bleeding patterns"}]},"_chembl":{"chemblId":"CHEMBL5082715","moleculeType":"Unknown","molecularWeight":"398.50"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PGL4001 acts as a progestin to suppress ovulation and alter endometrial conditions, preventing pregnancy. The drug-free period design allows for scheduled withdrawal bleeding, mimicking natural menstrual cycles while maintaining contraceptive efficacy. This approach combines hormonal contraception with a defined monthly cycle pattern.","oneSentence":"PGL4001 is a selective progesterone receptor modulator that provides contraceptive and menstrual regulation effects through progestin activity with a structured drug-free period.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:50:26.034Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hormonal contraception with scheduled menstrual cycling"}]},"trialDetails":[{"nctId":"NCT01252069","phase":"PHASE3","title":"PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)","status":"COMPLETED","sponsor":"PregLem SA","startDate":"2011-01","conditions":"Uterine Fibroids","enrollment":132}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ulipristal acetate"],"phase":"phase_3","status":"active","brandName":"PGL4001, progestin, drug free period","genericName":"PGL4001, progestin, drug free period","companyName":"PregLem SA","companyId":"preglem-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PGL4001 is a selective progesterone receptor modulator that provides contraceptive and menstrual regulation effects through progestin activity with a structured drug-free period. Used for Hormonal contraception with scheduled menstrual cycling.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}